Table 1 Basic characteristics of included studies
No | References | Sample size(T/C) | T/C (M/F) | Age (T/C) | Treatment | Treatment duration (T/C) | Main outcomes | |||
|---|---|---|---|---|---|---|---|---|---|---|
Intervention | Control | |||||||||
1 | Yu, et al. [21] | 102(64/38) | T(45/19) C(19/19) | 46.5(20–68) 51.5(21–69) | QFPD | CWM treatment | 10/10.5 | A1, A4 | ||
2 | Geng, et al. [15] | 75(47/28) | T(22/25) C(13/15) | 40.26 ± 12.33/39.47 ± 13.46 | QFPD + CWM treatment | CWM treatment | 9/9 | A2, A3, A4, B1, B2, B3 | ||
3 | Wang, et al. [25] | 72(42/30) | T(20/22) C(15/15) | 40.42 ± 12.59/41.79 ± 13.42 | QFPD + CWM treatment | CWM treatment | 16.20 ± 5.57/22.98 ± 5.84 | A2, A3, A6, C1 | ||
4 | Zhang, Pan [22] | 24(12/12) | T(6/6) C(7/5) | 61.42 ± 13.24/62.25 ± 14.69 | QFPD + CWM treatment | CWM treatment | 7/7 | A1,A7,C1,C2, C3 | ||
5 | Zeng, Ma, Wang et al. [24] | 229(104/125) | T(56/48) C(68/57) | 46.65 ± 6.21/46.21 ± 5.62 | QFPD + CWM treatment | CWM treatment | 24.63 ± 2.31/29.35 ± 2.47 | A2, A3, A7, C1 | ||
6 | Wang, et al. [14] | 140(70/70) | T(35/35) C(36/34) | 48.00 ± 13.2/49.4 ± 13.3 | QFPD + CWM treatment | CWM treatment | 7.03 ± 1.21/10.13 ± 2.36 | A1, A3, A4, A6, A7, C1, C2 | ||
7 | Yu, et al. [26] | 89(43/46) | T(21/22) C(18/28) | 64.23 ± 2.51/60.50 ± 2.08 | QFPD + CWM treatment | CWM treatment | 26.86 ± 1.76/33.46 ± 1.59 | A2, A3, A6, C2 | ||
8 | Li, Zhang [18] | 12(6/6) | T(4/2) C(3/3) | 52.00 ± 6.56/50.00 ± 10.00 | QFPD + CWM treatment | CWM treatment | 11.45 ± 4.58/19.40 ± 7.02 | A1, A3, A6, A7, C1 | ||
9 | Li, et al. [17] | 60(30/30) | T(15/15) C(13/17) | 53.600 ± 0.259/50.433 ± 0.338 | QFPD + CWM treatment | CWM treatment | 13.633 ± 0.398/16.433 ± 0.295 | A1, A3, A4, A6, A7, B1, B2, | ||
10 | Sun [19] | 62(31/31) | T(18/13) C(14/17) | 47.12 ± 6.14/46.57 ± 6.08 | QFPD + CWM treatment | CWM treatment | 12/12 | A1, C2, C3 | ||
11 | Xu, et al. [10] | 37(12/25) | T(6/6) C(13/12) | NR | QFPD + CWM treatment | CWM treatment | 12.2/16.8 | A2, A3 | ||
12 | Yang, Sun, Liu. [29] | 40(20/20) | T(13/7) C(12/8) | 50.16 ± 5.83/49.57 ± 5.46 | QFPD + CWM treatment | CWM treatment | 5.64 ± 2.03/5.51 ± 2.16 | B1, B2, B3, C1 | ||
13 | Zhang, et al. [27] | 8939(2568/6371) | T(1198/1370) C(2970/3410) | NR | QFPD + CWM treatment | CWM treatment | NR | A5, A6 | ||
14 | Xin, et al. [20] | 63(37/26) | T(17/20) C(12/14) | 40.1/50.7 | QFPD + CWM treatment | CWM treatment | 19/17 | A1, A3, A5, A7, C3 | ||
15 | Liu, et al. [23] | 446(223/223) | T(111/112) C(113/110) | 60 (51–66) /62(50–70) | QFPD + CWM treatment | CWM treatment | NR | A1, A5 | ||